Gray hair in mice signals successful elimination of cancer-prone stem cells. Study offers clues about melanoma risk in humans ...

University of Cincinnati reported positive Phase 2 melanoma trial results, with a third of patients responding to a combined ...

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune ...

More than half of melanoma patients whose cancer initially responds to immunotherapy will eventually see their disease return ...

A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found.

Because aircraft personnel are routinely exposed to galactic cosmic radiation and ultraviolet radiation, they face an elevated risk for certain cancers.

The Detroit Lions are announcing news on a beloved player who has been sidelined for more than a year following a cancer ...

AI and virtual care revolutionize dermatology, enhancing melanoma detection, expanding patient access and improving ...

Lung and skin cancer patients who were taking "checkpoint inhibitors" and had the COVID vaccine saw surprising results.

Immunocore's pipeline could offer long-term value beyond tebentafusp sales. See why I believe IMCR stock could qualify as a ...

An update from Evaxion Biotech ( ($EVAX) ) is now available. On November 7, 2025, Evaxion A/S announced new immune data from its phase 2 trial of ...